凱撒文化(002425.SZ)八天翻倍提示風險:與朝夕光年簽署的戰略合作協議為框架性協議
格隆匯 6 月 17日丨凱撒文化(002425.SZ)公佈,公司股價自6月8日至今漲幅累計超過100%。公司於2020年6月13日披露了《凱撒(中國)文化股份有限公司關於簽署戰略合作協議的公告》,公司與朝夕光年簽署的戰略合作協議為框架性協議,具體合作項目將由雙方另行簽署具體業務協議,在後續實施過程中受不可預測因素或不可抗力影響,可能產生協議部分內容或全部內容無法履行的風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.